With over 15 years in pharmaceutical R&D, this consultant excels in drug discovery, toxicology, and formulation development, leading teams from target identification to regulatory submissions
Expert in ADME/DMPK studies and pharmacokinetics, they have a proven track record in regulatory compliance, including GLP, GCP, FDA, and EMA standards, offering strategic consulting and scientific advisory roles
As an independent consultant, they have supported biotech firms with strategic R&D planning, regulatory submissions, and provided expert toxicological assessments for EMA scientific advice procedures
Led a team of 20 researchers in ADME/DMPK studies, overseeing non-clinical safety evaluations and representing the company in regulatory meetings with FDA and EMA